Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Non Operating Income (2016 - 2025)

Historic Non Operating Income for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $385022.9.

  • AC Immune's Non Operating Income rose 11888.91% to $385022.9 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 20301.09%. This contributed to the annual value of $1.7 million for FY2024, which is 34764.78% up from last year.
  • AC Immune's Non Operating Income amounted to $385022.9 in Q3 2025, which was up 11888.91% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Non Operating Income ranged from a high of $4.8 million in Q3 2021 and a low of -$2.2 million during Q2 2025
  • For the 5-year period, AC Immune's Non Operating Income averaged around $321653.8, with its median value being $65950.9 (2023).
  • As far as peak fluctuations go, AC Immune's Non Operating Income skyrocketed by 434103.68% in 2021, and later plummeted by 92809.11% in 2024.
  • Quarter analysis of 5 years shows AC Immune's Non Operating Income stood at $1.6 million in 2021, then plummeted by 103.16% to -$51901.1 in 2022, then tumbled by 399.59% to -$259291.5 in 2023, then surged by 1343.26% to $3.2 million in 2024, then plummeted by 88.06% to $385022.9 in 2025.
  • Its Non Operating Income was $385022.9 in Q3 2025, compared to -$2.2 million in Q2 2025 and $379277.4 in Q1 2025.